Gout in renal allograft recipients according to the pretransplant hyperuricemic status

Transplantation

Volumn 86, Issue 11, 2008, Pages 1543-1547

  Hernández Molina, Gabriela ^a   Cachafeiro Vilar, Antonio ^a   Villa, Antonio R ^a   Alberú, Josefina ^a   Rull Gabayet, Marina ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Gout; Hyperuricemia; Renal transplant

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; URIC ACID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GOUT; GRAFT RECIPIENT; HUMAN; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL; URIC ACID BLOOD LEVEL; KIDNEY DISEASE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GOUT; HUMANS; HYPERURICEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 58149355776     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818b22ed     Document Type: Article

References (18)

1. Lin H, Rocher L, McQuillan M, et al. Cyclosporine induced hyperuricemia and gout. N Eng J Med 1989; 321: 287.
2. Ahn KJ, Kim YS, Lee HC, et al. Cyclosporine induced hyperuricemia after renal transplant: Clinical characteristics and mechanism. Transplant Proc 1992; 24: 1391.
3. Mazzali M. Uric acid and transplantation. Semin Nephrol 2005; 25: 50.
4. Clive D. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000; 11: 974.
5. BieberJ, Terkeltaub R. Gout. On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004; 50: 2400.
6. Delaney V, Sumrani N, Daskalakis P, et al. Hyperuricemia and gout in renal allograft recipients. Transplant Proc 1992; 24: 1773.
7. Gores P, Fryd D, Sutherland D, et al. Hyperuricemia after renal transplantation. Am J Surg 1988; 156: 397.
8. Braun W, Richmon B, Protiva D, et al. The incidence and management of osteoporosis, gout and avascular necrosis in recipients of renal allografts functioning more than 20 years treated with prednisone and azathioprine. Transplant Proc 1999; 31: 1366.
9. Kanbay M, Akcay A, Huddam B, et al. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc 2005; 37: 3119.
10. HmidaB,Hachicha J, Bahloul Z, etal. Cyclosporine-induced hyperuri-cemia and gout in renal transplants. Transplant Proc 1995; 27: 2722.
11. Baethge B, Work J, Landreneau M, et al. Tophaceous gout in patients with renal transplants treated with cyclosporine A. J Rheumatol 1993; 20: 718.
12. Pascual E. Gout uptodate: From lab to the clinical and back. Curr Opin Rheumatol 2000; 12: 213.
13. Rott K, Agudelo C. Gout. JAMA 2003; 289: 2857.
14. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895.
15. Vázquez-Mellado J,Alvarez E,Burgos-VargasR.Primary prevention in rheumatology: The importance of hyperuricemia. Best Pract Res Clin Rheumatol 2004; 18: 111.
16. Akgul A, Bilgic A, Ibis A, et al. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc 2007; 39: 1023.
17. Shih-Ping Hsu, Mei-Fen Pai, Yu-Sen Peng, et al. Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 457.
18. Ifodu O, Tan C, Dulin A, et al. Gouty arthritis in end-stage renal disease: Clinical course and rarity of new cases. Am J Kidney Dis 1994; 23: 347.